MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MariMed's operating cash flow for the twelve months ending Sep 30, 2026 was $10.08M, up 161.7% year over year. For fiscal 2025 it was $7.70M, up 13.4% from the year before. The highest annual figure on record is $35.86M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.70M | +13.4% |
| FY2024 | Dec 31, 2024 | $6.79M | -14.2% |
| FY2023 | Dec 31, 2023 | $7.91M | +8.2% |
| FY2022 | Dec 31, 2022 | $7.31M | -79.6% |
| FY2021 | Dec 31, 2021 | $35.86M | +960.7% |
| FY2020 | Dec 31, 2020 | $3.38M | – |
| FY2019 | Dec 31, 2019 | -$24.14M | – |
| FY2018 | Dec 31, 2018 | -$2.91M | -264.8% |
| FY2017 | Dec 31, 2017 | $1.76M | – |
| FY2016 | Dec 31, 2016 | -$197.93K | – |
| FY2015 | Dec 31, 2015 | -$392.88K | – |
| FY2014 | Dec 31, 2014 | -$455.22K | – |
| FY2013 | Dec 31, 2013 | -$10.65K | – |
| FY2012 | Dec 31, 2012 | -$127.47K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.49M | +30.3% |
| Q2 FY2026 | Jun 30, 2026 | $2.22M | +647.1% |
| Q1 FY2026 | Mar 31, 2026 | $949.00K | -26.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.43M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.68M | +233.3% |
| Q2 FY2025 | Jun 30, 2025 | $297.00K | -90.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.29M | -59.7% |
| Q4 FY2024 | Dec 31, 2024 | -$413.00K | -112.8% |
| Q3 FY2024 | Sep 30, 2024 | $803.00K | -89.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.19M | +149.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.21M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.23M | +86.2% |
| Q3 FY2023 | Sep 30, 2023 | $7.90M | +136.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.50M | -153.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.74M | -77.2% |
| Q3 FY2022 | Sep 30, 2022 | $3.35M | -50.5% |
| Q2 FY2022 | Jun 30, 2022 | -$6.26M | -452.9% |
| Q1 FY2022 | Mar 31, 2022 | $8.49M | +696.2% |
| Q4 FY2021 | Dec 31, 2021 | $7.61M | +703.3% |
| Q1 FY2021 | Mar 31, 2021 | $6.76M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.77M | +3915.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.07M | – |
| Q2 FY2020 | Jun 30, 2020 | $946.96K | – |
| Q1 FY2020 | Mar 31, 2020 | -$407.11K | – |
| Q4 FY2019 | Dec 31, 2019 | $44.18K | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.13M | – |
| Q2 FY2019 | Jun 30, 2019 | -$15.83M | -1592.5% |
| Q1 FY2019 | Mar 31, 2019 | -$6.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.37M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.73M | -166.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.06M | – |
| Q1 FY2018 | Mar 31, 2018 | -$871.84K | -749.1% |
| Q4 FY2017 | Dec 31, 2017 | -$864.99K | -1182.2% |
| Q3 FY2017 | Sep 30, 2017 | $2.59M | – |
| Q2 FY2017 | Jun 30, 2017 | -$92.07K | – |
| Q1 FY2017 | Mar 31, 2017 | $134.32K | – |
| Q4 FY2016 | Dec 31, 2016 | $79.93K | – |
| Q3 FY2016 | Sep 30, 2016 | -$306.37K | – |
See a number that looks wrong?